about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

In­side the FDA’s ‘lis­ten­ing’ tour: Of­fi­cials agree US lags be­hind Chi­na on drug de­vel­op­ment

3 hours ago
R&D
FDA+

Q&A: New BIO chair to steer in­dus­try through ‘ex­is­ten­tial threats’ de­spite FDA re­cep­tiv­i­ty

2 days ago
R&D
China

Fired vac­cine ad­vi­sors de­fend ACIP’s work, in­de­pen­dence in joint ed­i­to­r­i­al

3 days ago
R&D
Pharma

Ab­b­Vie’s can­cer drug fails Phase 3 com­bo study to treat oth­er bone mar­row dis­eases

4 days ago
R&D
Pharma

Mod­er­na wins ex­pand­ed la­bel for RSV shot, al­low­ing use in at-risk, younger adults

Last week
Pharma
FDA+

Ex­clu­sive: Kennedy picks for vac­cine ad­vi­so­ry board were paid ex­perts against Mer­ck in civ­il cas­es

Last week
R&D
Pharma

RFK Jr. names eight new ACIP mem­bers, in­clud­ing pop­u­lar vac­cine crit­ic Robert Mal­one

Last week
Pharma
FDA+

Trump of­fi­cials seek price de­tails and weigh con­sumer sales as they ex­am­ine most fa­vored na­tion plan

Last week
Pharma

Fed­er­al of­fi­cials sched­ule three lis­ten­ing ses­sions this sum­mer to ad­dress drug com­pe­ti­tion

Last week
Pharma

FDA’s Makary says he wasn’t part of de­ci­sion to gut ACIP, de­fers pos­si­ble VRB­PAC changes to Prasad

Last week
R&D
Pharma

Up­dat­ed: HHS chief Kennedy re­moves all ACIP mem­bers, dis­man­tling vac­cine board

Last week
Pharma
FDA+

Up­dat­ed: Mer­ck wins FDA ap­proval for RSV an­ti­body drug, mak­ing a hot mar­ket more com­pet­i­tive

Last week
R&D
Pharma

FDA ap­proves Mod­er­na’s next-gen Covid vac­cine, with lim­its on most healthy peo­ple

3 weeks ago
Pharma
FDA+

HHS says it's pulled Covid shot guid­ance for healthy kids. The CDC vac­cine sched­ule shows oth­er­wise

3 weeks ago
Pharma
FDA+

Q&A: Why for­mer Sen. Kyrsten Sine­ma is back­ing a psy­che­del­ic med­i­cine with po­ten­tial­ly more up­side, but more risk

3 weeks ago
People
R&D

Up­dat­ed: Trump ad­min­is­tra­tion halts more than $750M in funds for Mod­er­na’s bird flu vac­cine

4 weeks ago
Pharma
Coronavirus

The fate of Mod­er­na’s next-gen Covid shot looms large af­ter a flur­ry of pol­i­cy changes

4 weeks ago
R&D
FDA+

RFK Jr. ends an­nu­al Covid vac­cine rec­om­men­da­tions for kids, preg­nant women

4 weeks ago
FDA+

Gil­gamesh’s short-act­ing psy­che­del­ic drug shows rapid ef­fect in Phase 2 de­pres­sion study

4 weeks ago
R&D

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

4 weeks ago
Pharma

Volas­tra un­veils first hu­man da­ta of its sol­id tu­mor drug tar­get

4 weeks ago
R&D

Up­dat­ed: FDA ex­pects 'time­ly avail­abil­i­ty' of Covid shots as ad­vi­sors up­date for­mu­la rec­om­men­da­tion

5 weeks ago
FDA+
Coronavirus

The ‘MA­HA re­port’: Four key take­aways on vac­cines, med­i­cine and the phar­ma in­dus­try

5 weeks ago
Pharma
FDA+

FDA asks Covid vac­cine mak­ers to add more my­ocardi­tis da­ta to la­bels

5 weeks ago
Pharma
FDA+
1234 Next page Last page
A service from the Financial Times